Brown, Lisle/Cummings, Inc. GSK PLC Transaction History

Brown, Lisle/Cummings, Inc.

  • $329 Billion
  • Q3 2024
Number of Shares
600
Previous 932 35.62%
Holding current value
$24.5 Million
Previous $35.9 Million 31.63%
% of portfolio
0.01%
Previous 0.01%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
SELL
N/A
-332 Reduced 35.62%
600 $24.5 Million
Q2 2024

Jul 17, 2024
SELL
N/A
-1,044 Reduced 52.83%
932 $35.9 Million
Q1 2024

Jun 28, 2024
SELL
N/A
-5,389 Reduced 73.17%
1,976 $84.7 Million
Q4 2023

Jun 28, 2024
BUY
N/A
238 Added 3.34%
7,365 $273 Million
Q3 2023

Jun 28, 2024
SELL
N/A
-1,242 Reduced 14.84%
7,127 $258 Million
Q2 2023

Jun 28, 2024
SELL
N/A
-870 Reduced 9.42%
8,369 $298 Million
Q1 2023

Jun 28, 2024
BUY
N/A
1,010 Added 12.27%
9,239 $329 Million
Q4 2022

Jun 28, 2024
SELL
N/A
-1,741 Reduced 17.46%
8,229 $289 Million
Q3 2022

Jun 28, 2024
BUY
N/A
9,970 New
9,970 $293 Million
Track This Portfolio

Track Brown, Lisle/Cummings, Inc. Portfolio

Follow Brown, Lisle/Cummings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown, Lisle/Cummings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brown, Lisle/Cummings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email